A 4-year-old white boy with immune-mediated red cell aplasia and severe anemia was given high intravenous doses of γ-globulin. The therapy was well tolerated and followed by complete resolution of the inhibition of erythropolesis with no recurrence of diseases. Eight months after discontinuation of treatment, the patient has a normal complete blood cell count.
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health